Fintel reports that on April 17, 2025, BMO Capital downgraded their outlook for Novo Nordisk A (NYSE:NVO) from Outperform to ...

BMO Capital raised the firm’s price target on Azek (AZEK) to $57 from $54 and keeps a Market Perform rating on the shares. The company’s acquisition by James Hardie (JHX) is very good from an ...

Brian Belski, the top strategist at BMO Capital Markets, just cut his S&P 500 price target. Here are 42 stocks to consider for strong dividend growth as prices continue to surge. The biggest ...

BMO Capital downgraded Novo Nordisk (NVO) to Market Perform from Outperform with a price target of $64, down from $105. The company’s obesity ...

Fintel reports that on March 28, 2025, BMO Capital upgraded their outlook for ... in CHKP by 3.37% over the last quarter. Boston Partners holds 3,518K shares representing 3.25% ownership of ...

BMO Capital lowered the firm’s price target on FactSet (FDS) to $466 from $498 and keeps a Market Perform rating on the shares. The company reported a margin-driven adjusted EPS beat ...

Alphabet (NASDAQ:GOOGL – Get Free Report)‘s stock had its “outperform” rating reiterated by stock analysts at BMO Capital Markets in a research note issued on Thursday,Benzinga reports.

Fintel reports that on March 27, 2025, BMO Capital initiated coverage of Baldwin ... (This description is provided by the company.) baldwin risk partners is an insurance distribution holding ...

BMO CAPP Energy Symposium provides a key forum for the energy industry to connect with the investment community and facilitates discussion on corporate strategies, industry performance and emerging ...